This panel studies mismatch repair proteins in Hereditary Nonpolyposis Colorectal cancer. These biomarkers are used for better understanding of the kinetics and effectiveness of a drug. It detects early signals of efficacy for rapidly evaluating the impact of potential disease-modifying therapies.